These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11602813)

  • 61. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias.
    Byrd RC; Sung RJ; Marks J; Parmley WW
    J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique.
    Reves JG; Croughwell ND; Hawkins E; Smith LR; Jacobs JR; Rankin S; Lowe J; VanTrigt P
    J Thorac Cardiovasc Surg; 1990 Aug; 100(2):221-7. PubMed ID: 1974664
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group.
    Anderson S; Blanski L; Byrd RC; Das G; Engler R; Laddu A; Lee R; Rajfer S; Schroeder J; Steck JD
    Am Heart J; 1986 Jan; 111(1):42-8. PubMed ID: 2868645
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The central and peripheral hemodynamics of celiprolol.
    Mancia G
    Am Heart J; 1988 Nov; 116(5 Pt 2):1405-11. PubMed ID: 2903651
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
    Klinger D
    Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of esmolol in hypertension after cardiac surgery.
    Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
    Am J Cardiol; 1985 Oct; 56(11):49F-56F. PubMed ID: 2864849
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol.
    Heublein B; Modersohn D; Franz N; Panzner B
    Eur Heart J; 1991 May; 12(5):617-23. PubMed ID: 1678705
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Esmolol Administration to Control Tachycardia in an Ovine Model of Peritonitis.
    Hosokawa K; Su F; Taccone FS; Post EH; Pereira AJ; Herpain A; Creteur J; Vincent JL
    Anesth Analg; 2017 Dec; 125(6):1952-1959. PubMed ID: 28708664
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
    Buchwald A; Unterberg C; van der Does R; Wiegand V
    Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics of esmolol in children.
    Wiest DB; Trippel DL; Gillette PC; Garner SS
    Clin Pharmacol Ther; 1991 Jun; 49(6):618-23. PubMed ID: 1676357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients.
    Boldt J; Brosch C; Lehmann A; Suttner S; Isgro F
    Anesth Analg; 2004 Oct; 99(4):1009-1017. PubMed ID: 15385341
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Esmolol for the management of pediatric hypertension after cardiac operations.
    Wiest DB; Garner SS; Uber WE; Sade RM
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):890-7. PubMed ID: 9576226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.
    Natale A; Newby KH; Dhala A; Akhtar M; Sra J
    J Cardiovasc Electrophysiol; 1996 Dec; 7(12):1154-8. PubMed ID: 8985804
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute effects of nicardipine and esmolol on the cardiac cycle, intracardiac hemodynamic and endothelial shear stress in patients with unstable angina pectoris and moderate coronary stenosis: results from single center, randomized study.
    Chen SL; Hu ZY; Zhang JJ; Ye F; Kan J; Xu T; Liu ZZ; Zhang YJ; Zhang JX; Chen M
    Cardiovasc Ther; 2012 Jun; 30(3):162-71. PubMed ID: 22099625
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Acute hemodynamic effects of piroximone i.v. in patients with severe heart failure].
    Scholz M; Kneissl GD; Winkelmann BW; Grohe G; Klittich P; Bussmann WD
    Z Kardiol; 1995 Oct; 84(10):827-33. PubMed ID: 7502570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.